Data Scientist (Bioinformatics)
-
Apply Now Application ends in 9d 19h 20min
Job Detail
-
Offered Salary 0
Job Description
About the job
We are seeking a Computational Scientists/Bioinformaticians to work on implementing analytic pipelines, data QC, computational analysis, and/or interpretation for clinical data generated from high throughput next generation sequencing platforms. Computational expertise such as Python, Java, or Perl and proficiency in Linux and Grid/cloud computing familiarity are plus and desirable.
This position will be based in the Psomagen office in Rockville, Maryland.
Responsibilities
- Carrying out Next generation data analysis and QC for below categories:
- DNA sequencing data analysis (WGS/WES)
- Non-DNA sequencing data analysis (WTS/Epigenomics)
- Data management on Linux environment
- Data delivery
- Perform customized data analysis – Build customized analytic pipelines
Qualifications / Preferences
- Bachelor or higher degree relevant to Biology/Bioinformatics/Computer Science fields are required
- Good communication, interpersonal and presentation skills for team works are required
- Biological backgrounds with a desire to work in a computational environment are a plus
- Familiarity with Linux/Unix environment and shell script programming are preferred
- Prior experiences with NGS data analysis are a plus, especially in 10X application
- Experience using bioinformatics tools and familiarity with genomic database are a plus
Benefits
- Medical, dental, and vision insurance (Monthly insurance premium is covered 100% by the employer)
- 401(k) Plan + company match
- Cashable/Non-cashable time-off vacation
- Long-term employment cashable vacation
- 2-hour off for an annual check-up
- Money Gifts for congratulatory/condolences
- Lunch allowance and drinkware reimbursement
Company Overview
Psomagen, Inc., founded in 2004 in Rockville, MD, is at the forefront of genetic and genomic testing. The company offers cutting-edge genomic services through next-generation and Sanger sequencing with data analysis services for applications in basic research and clinic diagnostics. The service laboratory has been certified under the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP), which demonstrates the highest level of quality and safety in the market.
Listed on the KOSDAQ in July 2020, the company is rapidly expanding its business from B2B to B2C and from Research to Clinical markets. The company has broadened the capabilities in the healthcare space such as at-home kits for analysis of genetic traits and microbiome profiles. With CLIA-certified and CAP-accredited laboratories, the company is looking to further expand service offerings in the clinical laboratory diagnostics market such as a laboratory-developed test (LDT) for COVID-19.